 | • レポートコード：MRC2-11QY01424 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はヒトサイトメガロウイルス65kDaリンタンパク質のグローバル市場について調査・分析したレポートです。種類別（HB-101、CyMVectin、ASP-0113、PepVax、その他）市場規模、用途別（脳腫瘍、血液腫瘍、腎移植拒絶反応、肝移植拒絶反応、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ヒトサイトメガロウイルス65kDaリンタンパク質の競争状況、市場シェア ・世界のヒトサイトメガロウイルス65kDaリンタンパク質市場：種類別市場規模 2015年-2020年（HB-101、CyMVectin、ASP-0113、PepVax、その他） ・世界のヒトサイトメガロウイルス65kDaリンタンパク質市場：種類別市場規模予測 2021年-2026年（HB-101、CyMVectin、ASP-0113、PepVax、その他） ・世界のヒトサイトメガロウイルス65kDaリンタンパク質市場：用途別市場規模 2015年-2020年（脳腫瘍、血液腫瘍、腎移植拒絶反応、肝移植拒絶反応、その他） ・世界のヒトサイトメガロウイルス65kDaリンタンパク質市場：用途別市場規模予測 2021年-2026年（脳腫瘍、血液腫瘍、腎移植拒絶反応、肝移植拒絶反応、その他） ・北米のヒトサイトメガロウイルス65kDaリンタンパク質市場分析：米国、カナダ ・ヨーロッパのヒトサイトメガロウイルス65kDaリンタンパク質市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのヒトサイトメガロウイルス65kDaリンタンパク質市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のヒトサイトメガロウイルス65kDaリンタンパク質市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのヒトサイトメガロウイルス65kDaリンタンパク質市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Astellas Pharma Inc、Hookipa Biotech AG、Immunomic Therapeutics Inc、Vakzine Projekt Management GmbH、Vaximm AG、VBI Vaccines Inc、Vical Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Human cytomegalovirus 65 kDa Phosphoprotein Market
The global Human cytomegalovirus 65 kDa Phosphoprotein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Human cytomegalovirus 65 kDa Phosphoprotein Scope and Market Size
Human cytomegalovirus 65 kDa Phosphoprotein market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human cytomegalovirus 65 kDa Phosphoprotein market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Human cytomegalovirus 65 kDa Phosphoprotein market is segmented into
HB-101
CyMVectin
ASP-0113
PepVax
Others
Segment by Application, the Human cytomegalovirus 65 kDa Phosphoprotein market is segmented into
Brain Tumor
Hemotaological Tumor
Kidney Transplant Rejection
Liver Transplant Rejection
Others
Regional and Country-level Analysis
The Human cytomegalovirus 65 kDa Phosphoprotein market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human cytomegalovirus 65 kDa Phosphoprotein market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human cytomegalovirus 65 kDa Phosphoprotein Market Share Analysis
Human cytomegalovirus 65 kDa Phosphoprotein market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human cytomegalovirus 65 kDa Phosphoprotein business, the date to enter into the Human cytomegalovirus 65 kDa Phosphoprotein market, Human cytomegalovirus 65 kDa Phosphoprotein product introduction, recent developments, etc.
The major vendors covered:
Astellas Pharma Inc
Hookipa Biotech AG
Immunomic Therapeutics Inc
Vakzine Projekt Management GmbH
Vaximm AG
VBI Vaccines Inc
Vical Inc
…
1 Study Coverage
1.1 Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction
1.2 Market Segments
1.3 Key Human cytomegalovirus 65 kDa Phosphoprotein Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size Growth Rate by Type
1.4.2 HB-101
1.4.3 CyMVectin
1.4.4 ASP-0113
1.4.5 PepVax
1.4.6 Others
1.5 Market by Application
1.5.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size Growth Rate by Application
1.5.2 Brain Tumor
1.5.3 Hemotaological Tumor
1.5.4 Kidney Transplant Rejection
1.5.5 Liver Transplant Rejection
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size, Estimates and Forecasts
2.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue 2015-2026
2.1.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales 2015-2026
2.2 Global Human cytomegalovirus 65 kDa Phosphoprotein, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human cytomegalovirus 65 kDa Phosphoprotein Competitor Landscape by Players
3.1 Human cytomegalovirus 65 kDa Phosphoprotein Sales by Manufacturers
3.1.1 Human cytomegalovirus 65 kDa Phosphoprotein Sales by Manufacturers (2015-2020)
3.1.2 Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Manufacturers (2015-2020)
3.2 Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Manufacturers
3.2.1 Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Manufacturers (2015-2020)
3.2.2 Human cytomegalovirus 65 kDa Phosphoprotein Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human cytomegalovirus 65 kDa Phosphoprotein Revenue in 2019
3.2.5 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human cytomegalovirus 65 kDa Phosphoprotein Price by Manufacturers
3.4 Human cytomegalovirus 65 kDa Phosphoprotein Manufacturing Base Distribution, Product Types
3.4.1 Human cytomegalovirus 65 kDa Phosphoprotein Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human cytomegalovirus 65 kDa Phosphoprotein Product Type
3.4.3 Date of International Manufacturers Enter into Human cytomegalovirus 65 kDa Phosphoprotein Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Type (2015-2020)
4.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2015-2020)
4.1.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Type (2015-2020)
4.1.3 Human cytomegalovirus 65 kDa Phosphoprotein Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size Forecast by Type (2021-2026)
4.2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Type (2021-2026)
4.2.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Type (2021-2026)
4.2.3 Human cytomegalovirus 65 kDa Phosphoprotein Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Application (2015-2020)
5.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2015-2020)
5.1.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Application (2015-2020)
5.1.3 Human cytomegalovirus 65 kDa Phosphoprotein Price by Application (2015-2020)
5.2 Human cytomegalovirus 65 kDa Phosphoprotein Market Size Forecast by Application (2021-2026)
5.2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Application (2021-2026)
5.2.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Application (2021-2026)
5.2.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Price Forecast by Application (2021-2026)
6 North America
6.1 North America Human cytomegalovirus 65 kDa Phosphoprotein by Country
6.1.1 North America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country
6.1.2 North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human cytomegalovirus 65 kDa Phosphoprotein Market Facts & Figures by Type
6.3 North America Human cytomegalovirus 65 kDa Phosphoprotein Market Facts & Figures by Application
7 Europe
7.1 Europe Human cytomegalovirus 65 kDa Phosphoprotein by Country
7.1.1 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country
7.1.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Market Facts & Figures by Type
7.3 Europe Human cytomegalovirus 65 kDa Phosphoprotein Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein by Region
8.1.1 Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales by Region
8.1.2 Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Market Facts & Figures by Type
8.3 Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Market Facts & Figures by Application
9 Latin America
9.1 Latin America Human cytomegalovirus 65 kDa Phosphoprotein by Country
9.1.1 Latin America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country
9.1.2 Latin America Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human cytomegalovirus 65 kDa Phosphoprotein Market Facts & Figures by Type
9.3 Central & South America Human cytomegalovirus 65 kDa Phosphoprotein Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein by Country
10.1.1 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country
10.1.2 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Market Facts & Figures by Type
10.3 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Market Facts & Figures by Application
11 Company Profiles
11.1 Astellas Pharma Inc
11.1.1 Astellas Pharma Inc Corporation Information
11.1.2 Astellas Pharma Inc Description and Business Overview
11.1.3 Astellas Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Products Offered
11.1.5 Astellas Pharma Inc Related Developments
11.2 Hookipa Biotech AG
11.2.1 Hookipa Biotech AG Corporation Information
11.2.2 Hookipa Biotech AG Description and Business Overview
11.2.3 Hookipa Biotech AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Products Offered
11.2.5 Hookipa Biotech AG Related Developments
11.3 Immunomic Therapeutics Inc
11.3.1 Immunomic Therapeutics Inc Corporation Information
11.3.2 Immunomic Therapeutics Inc Description and Business Overview
11.3.3 Immunomic Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Products Offered
11.3.5 Immunomic Therapeutics Inc Related Developments
11.4 Vakzine Projekt Management GmbH
11.4.1 Vakzine Projekt Management GmbH Corporation Information
11.4.2 Vakzine Projekt Management GmbH Description and Business Overview
11.4.3 Vakzine Projekt Management GmbH Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Products Offered
11.4.5 Vakzine Projekt Management GmbH Related Developments
11.5 Vaximm AG
11.5.1 Vaximm AG Corporation Information
11.5.2 Vaximm AG Description and Business Overview
11.5.3 Vaximm AG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Products Offered
11.5.5 Vaximm AG Related Developments
11.6 VBI Vaccines Inc
11.6.1 VBI Vaccines Inc Corporation Information
11.6.2 VBI Vaccines Inc Description and Business Overview
11.6.3 VBI Vaccines Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Products Offered
11.6.5 VBI Vaccines Inc Related Developments
11.7 Vical Inc
11.7.1 Vical Inc Corporation Information
11.7.2 Vical Inc Description and Business Overview
11.7.3 Vical Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Products Offered
11.7.5 Vical Inc Related Developments
11.1 Astellas Pharma Inc
11.1.1 Astellas Pharma Inc Corporation Information
11.1.2 Astellas Pharma Inc Description and Business Overview
11.1.3 Astellas Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Products Offered
11.1.5 Astellas Pharma Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human cytomegalovirus 65 kDa Phosphoprotein Market Estimates and Projections by Region
12.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Regions 2021-2026
12.1.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Regions 2021-2026
12.2 North America Human cytomegalovirus 65 kDa Phosphoprotein Market Size Forecast (2021-2026)
12.2.1 North America: Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast (2021-2026)
12.2.2 North America: Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast (2021-2026)
12.2.3 North America: Human cytomegalovirus 65 kDa Phosphoprotein Market Size Forecast by Country (2021-2026)
12.3 Europe Human cytomegalovirus 65 kDa Phosphoprotein Market Size Forecast (2021-2026)
12.3.1 Europe: Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast (2021-2026)
12.3.2 Europe: Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast (2021-2026)
12.3.3 Europe: Human cytomegalovirus 65 kDa Phosphoprotein Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human cytomegalovirus 65 kDa Phosphoprotein Market Size Forecast by Region (2021-2026)
12.5 Latin America Human cytomegalovirus 65 kDa Phosphoprotein Market Size Forecast (2021-2026)
12.5.1 Latin America: Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast (2021-2026)
12.5.2 Latin America: Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast (2021-2026)
12.5.3 Latin America: Human cytomegalovirus 65 kDa Phosphoprotein Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human cytomegalovirus 65 kDa Phosphoprotein Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Human cytomegalovirus 65 kDa Phosphoprotein Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human cytomegalovirus 65 kDa Phosphoprotein Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Human cytomegalovirus 65 kDa Phosphoprotein Market Segments
Table 2. Ranking of Global Top Human cytomegalovirus 65 kDa Phosphoprotein Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of HB-101
Table 5. Major Manufacturers of CyMVectin
Table 6. Major Manufacturers of ASP-0113
Table 7. Major Manufacturers of PepVax
Table 8. Major Manufacturers of Others
Table 9. Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Regions (2015-2020)
Table 13. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Share by Manufacturers (2015-2020)
Table 16. Global Human cytomegalovirus 65 kDa Phosphoprotein Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Human cytomegalovirus 65 kDa Phosphoprotein by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human cytomegalovirus 65 kDa Phosphoprotein as of 2019)
Table 18. Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Human cytomegalovirus 65 kDa Phosphoprotein Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Human cytomegalovirus 65 kDa Phosphoprotein Price (2015-2020) (USD/Pcs)
Table 21. Human cytomegalovirus 65 kDa Phosphoprotein Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Human cytomegalovirus 65 kDa Phosphoprotein Product Type
Table 23. Date of International Manufacturers Enter into Human cytomegalovirus 65 kDa Phosphoprotein Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2015-2020) (K Pcs)
Table 26. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Share by Type (2015-2020)
Table 27. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Share by Type (2015-2020)
Table 29. Human cytomegalovirus 65 kDa Phosphoprotein Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2015-2020) (K Pcs)
Table 31. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Share by Application (2015-2020)
Table 32. North America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country (2015-2020) (K Pcs)
Table 33. North America Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Country (2015-2020)
Table 34. North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country (2015-2020)
Table 36. North America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2015-2020) (K Pcs)
Table 37. North America Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type (2015-2020)
Table 38. North America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2015-2020) (K Pcs)
Table 39. North America Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application (2015-2020)
Table 40. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Country (2015-2020)
Table 42. Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country (2015-2020)
Table 44. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type (2015-2020)
Table 46. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application (2015-2020)
Table 56. Latin America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country (2015-2020)
Table 60. Latin America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type (2015-2020)
Table 62. Latin America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application (2015-2020)
Table 72. Astellas Pharma Inc Corporation Information
Table 73. Astellas Pharma Inc Description and Major Businesses
Table 74. Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Astellas Pharma Inc Product
Table 76. Astellas Pharma Inc Recent Development
Table 77. Hookipa Biotech AG Corporation Information
Table 78. Hookipa Biotech AG Description and Major Businesses
Table 79. Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Hookipa Biotech AG Product
Table 81. Hookipa Biotech AG Recent Development
Table 82. Immunomic Therapeutics Inc Corporation Information
Table 83. Immunomic Therapeutics Inc Description and Major Businesses
Table 84. Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Immunomic Therapeutics Inc Product
Table 86. Immunomic Therapeutics Inc Recent Development
Table 87. Vakzine Projekt Management GmbH Corporation Information
Table 88. Vakzine Projekt Management GmbH Description and Major Businesses
Table 89. Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Vakzine Projekt Management GmbH Product
Table 91. Vakzine Projekt Management GmbH Recent Development
Table 92. Vaximm AG Corporation Information
Table 93. Vaximm AG Description and Major Businesses
Table 94. Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Vaximm AG Product
Table 96. Vaximm AG Recent Development
Table 97. VBI Vaccines Inc Corporation Information
Table 98. VBI Vaccines Inc Description and Major Businesses
Table 99. VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. VBI Vaccines Inc Product
Table 101. VBI Vaccines Inc Recent Development
Table 102. Vical Inc Corporation Information
Table 103. Vical Inc Description and Major Businesses
Table 104. Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Vical Inc Product
Table 106. Vical Inc Recent Development
Table 107. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Regions (2021-2026) (K Pcs)
Table 108. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share Forecast by Regions (2021-2026)
Table 109. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 110. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share Forecast by Regions (2021-2026)
Table 111. North America: Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. North America: Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Europe: Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Europe: Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Asia Pacific: Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Region (2021-2026) (K Pcs)
Table 116. Asia Pacific: Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Region (2021-2026) (US$ Million)
Table 117. Latin America: Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Country (2021-2026) (K Pcs)
Table 118. Latin America: Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Middle East and Africa: Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Country (2021-2026) (K Pcs)
Table 120. Middle East and Africa: Human cytomegalovirus 65 kDa Phosphoprotein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Main Points Interviewed from Key Human cytomegalovirus 65 kDa Phosphoprotein Players
Table 125. Human cytomegalovirus 65 kDa Phosphoprotein Customers List
Table 126. Human cytomegalovirus 65 kDa Phosphoprotein Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Human cytomegalovirus 65 kDa Phosphoprotein Product Picture
Figure 2. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type in 2020 & 2026
Figure 3. HB-101 Product Picture
Figure 4. CyMVectin Product Picture
Figure 5. ASP-0113 Product Picture
Figure 6. PepVax Product Picture
Figure 7. Others Product Picture
Figure 8. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application in 2020 & 2026
Figure 9. Brain Tumor
Figure 10. Hemotaological Tumor
Figure 11. Kidney Transplant Rejection
Figure 12. Liver Transplant Rejection
Figure 13. Others
Figure 14. Human cytomegalovirus 65 kDa Phosphoprotein Report Years Considered
Figure 15. Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size 2015-2026 (US$ Million)
Figure 16. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales 2015-2026 (K Pcs)
Figure 17. Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Region (2015-2020)
Figure 19. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Region in 2019
Figure 20. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Region (2015-2020)
Figure 21. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Region in 2019
Figure 22. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Human cytomegalovirus 65 kDa Phosphoprotein Revenue in 2019
Figure 24. Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type (2015-2020)
Figure 26. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type in 2019
Figure 27. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Type (2015-2020)
Figure 28. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Type in 2019
Figure 29. Global Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Price Range (2015-2020)
Figure 30. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application (2015-2020)
Figure 31. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application in 2019
Figure 32. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Application (2015-2020)
Figure 33. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Application in 2019
Figure 34. North America Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Country in 2019
Figure 37. North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country in 2019
Figure 38. U.S. Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Type in 2019
Figure 43. North America Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Application in 2019
Figure 44. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Country in 2019
Figure 47. Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country in 2019
Figure 48. Germany Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Type in 2019
Figure 59. Europe Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Application in 2019
Figure 60. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Region in 2019
Figure 63. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Region in 2019
Figure 64. China Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Type in 2019
Figure 87. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Application in 2019
Figure 88. Latin America Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Country in 2019
Figure 91. Latin America Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country in 2019
Figure 92. Mexico Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Type in 2019
Figure 99. Latin America Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Application in 2019
Figure 100. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Country in 2019
Figure 104. Turkey Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Type in 2019
Figure 111. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Application in 2019
Figure 112. North America Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
サイトメガロウイルス（CMV）感染症の世界市場（～2026年） Cytomegalovirus (CMV) infection is one of the common herpesvirus infection with different symptoms, which occurs in people of all ages across the globe. This viral infection is communicable and can easily spread through body fluids such as blood, urine, saliva, semen and breast milk. The infection c…- サイトメガロウイルス（CMV）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Cytomegalovirus Therapeutics Market The global Cytomegalovirus Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cytomegalovirus Therapeutics Scope and Market Size Cytome…
- サイトメガロウイルス（CMV）網膜炎治療の世界市場（～2026年） Ophthalmology is the branch of medical science that deals with the management and study of anatomy, physiology, and diseases related to the human eye. Globally, the incidence of eye disorders and vision loss are becoming major public health issues. Some of the major eye diseases include age-related …
- サイトメガロウイルス（HHV-5）感染症治療薬の世界市場（～2026年） A drug used to treat giant cell infections. Market Analysis and Insights: Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market The global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of X…
- 組換えヒトアルブミンの世界市場（～2026年） Recombinant human albumin (rHA) is a highly purified animal-, virus-, and prion-free product developed as an alternative to human serum albumin (HSA), to which it is structurally equivalent. Market Analysis and Insights: Global Recombinant Human Albumin Market The global Recombinant Human Albumin ma…